Levy Howard 4
4 · CATALYST BIOSCIENCES, INC. · Filed Jan 28, 2019
Insider Transaction Report
Form 4
Levy Howard
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-01-24+35,000→ 35,000 totalExercise: $7.97Exp: 2029-01-24→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]Award vests over a four (4) year period on each monthly anniversary commencing January 24, 2019.